SCHEMBL7946719

SCHEMBL7946719

Cc1csc(C(=O)Nc2ccc(F)c(CNc3cccnc3N)c2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 9/20 0.43
AURKA O14965 1/20 0.39
AURKB Q96GD4 1/20 0.39
GRM4 Q14833 3/20 0.38
HDAC4 P56524 3/20 0.37
MEF2D Q14814 1/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
PDGFRB P09619 3/20 0.37
KDR P35968 3/20 0.37
HDAC3 O15379 2/20 0.37
ABL1 P00519 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC7 Q8WUI4 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC10 Q969S8 2/20 0.37
HDAC11 Q96DB2 2/20 0.37
HDAC8 Q9BY41 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7944905 0.86 BACE1 (0.43) BACE1AURKAAURKBHDAC4PDGFRB
SCHEMBL7940384 0.84 BACE1 (0.44) BACE1CASP3SENP8SENP7SENP6
SCHEMBL7942157 0.84 BACE1 (0.60) BACE1AURKAAURKBHDAC4MEF2D
SCHEMBL7943395 0.83 BACE1 (0.48) BACE1HDAC4CASP3SENP8SENP7
SCHEMBL7944814 0.83 BACE1 (0.52) BACE1AURKAAURKBGRM4HDAC4
SCHEMBL7941994 0.82 GAA (0.42) BACE1AURKAAURKBHDAC4MEF2D
SCHEMBL7940524 0.82 BACE1 (0.50) BACE1AURKAAURKBGRM4HDAC4
SCHEMBL7943475 0.81 BACE1 (0.47) BACE1AURKAAURKBGRM4HDAC4
SCHEMBL7943474 0.81 BACE1 (0.43) BACE1AURKAAURKBHDAC1VCP
SCHEMBL7941823 0.81 BACE1 (0.46) BACE1AURKAAURKBGRM4HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237576-A1 2-AMINOPYRIMIDIN-4-ONE AND 2-AMINOPYRIDINE DERIVATIVES BOTH HAVING BACE1-INHIBITING ACTIVITY SHIONOGI & CO., LTD. (JP) 2011-09-29 US disclosed
WO-2010047372-A1 2-AMINOPYRIDIN-4-ONE AND 2-AMINOPYRIDINE DERIVATIVE BOTH HAVING BACE1-INHIBITING ACTIVITY 塩野義製薬株式会社 (JP) 2010-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237576-A1 2-AMINOPYRIMIDIN-4-ONE AND 2-AMINOPYRIDINE DERIVATIVES BOTH HAVING BACE1-INHIBITING ACTIVITY BACE1, APP, BACE2 BACE1 1/4885AURKA 3552/4885AURKB 2842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.